1. Dr. Basavaraj K. NanjwadeDr. Basavaraj K. Nanjwade M. Pharm., Ph.DM. Pharm., Ph.D
Professor of Pharmaceutics
Department of Pharmaceutics
KLE University College of Pharmacy
JN Medical College Campus
BELGAUM – 590010
Cell No: 00919742431000
E-mail: bknanjwade@yahoo.co.in

2. Applications of Nanotechnology
05 March. 2011 2M S Ramaiah Institute of Technology, Bangalore

3. Introduction (Nanotechnology)
The prefix nano comes from the Greek word nanos,
which means one-billionth part of something.
So, nanotechnology can be described as engineering
and manufacturing at the scale of a nanometer or
nanoscale (nanometer = 10-9
meter).
Examples of nano-substance are- Atom diameter 0.15
nm, diameter of double strand DNA 2 nm, and cell
1000 nm.
05 March. 2011 3M S Ramaiah Institute of Technology, Bangalore

4. Cell Structure
05 March. 2011 4M S Ramaiah Institute of Technology, Bangalore

5. Introduction (Nanotechnology)
The aim of nano-scientists is to virtually imitate
nature.
 They are trying to construct objects out of their most
basic components, atom by atom, the way that nature
does.
This offers an unprecedented degree of precision and
control over thefinal product.
05 March. 2011 5M S Ramaiah Institute of Technology, Bangalore

6. Introduction (Nanotechnology)
As a fundamental understanding of how nature works
at the atomic scale.
We can consider nanotechnology as enabling
technology; it will enable us to do radical new things
in virtually every technological and scientific arena.
05 March. 2011 6M S Ramaiah Institute of Technology, Bangalore

7. Introduction (Nanotechnology)
However, despite great investments and hard
scientific work, things are actually moving a bit
slowly.
Most scientists believe that nanotechnology will start
seriously influence our lives around the year 2020
05 March. 2011 7M S Ramaiah Institute of Technology, Bangalore

8. Targeted Drug Delivery
05 March. 2011 M S Ramaiah Institute of Technology, Bangalore 8

9. Advantages of Nanotechnology
Nanotechnology may help in increasing the solubility &
bioavailability of drugs.
New dosage forms and better exploration of less-used
drug administration routes for efficient therapeutic
outcomes.
Nanoparticles with diameter less than 200nm are not
screened out of circulation by liver and spleen.
05 March. 2011 9M S Ramaiah Institute of Technology, Bangalore

10. Advantages of Nanotechnology
Nanotechnology is better suited for drug targeting of
individual tissues.
Cells and cellular receptors and hence, more suitable
for gene and vaccine delivery.
It may also be helpful in designing nanoporous
membranes for controlled-delivery drug devices.
05 March. 2011 10M S Ramaiah Institute of Technology, Bangalore

11. Advantages of Nanotechnology
Nanoscale powders of antiasthma and analgesic drugs
are quickly absorbed in the human body in
comparison to the traditional drug delivery systems.
Nanotechnology isparticularly useful in caseof drugs
with narrow therapeutic indices.
05 March. 2011 11M S Ramaiah Institute of Technology, Bangalore

12. It has been shown that self-assemblies (~ 15nm) of
phospholipid molecules known as sterically stabilized
micelles are helpful in improving efficacy and reducing
toxicity of such drugs.
Thesideeffect of vasoactiveintestinal peptidedelivered
by this nanotechnology was completely eliminated as it
extravasated specifically in diseased tissues.
Advantages of Nanotechnology
05 March. 2011 12M S Ramaiah Institute of Technology, Bangalore

13. Advantages of Nanotechnology
Nanotech based drug delivery is less toxic as well as
inexpensive.
Nanotechnology is suited for better drugs delivery to
small regions within the human body as such drugs
can easily crossbiological membranes.
Liposomes are effective for drug targeting by
chemotherapeutic agents.
05 March. 2011 13M S Ramaiah Institute of Technology, Bangalore

14. Nanotechnology – Applications
05 March. 2011 M S Ramaiah Institute of Technology, Bangalore 14

15. Nanotechnology – based drug delivery
Systems
Nanoparticles can be used in targeted drug delivery at
the site of disease to improve the uptake of poorly
soluble drugs, the targeting of drugs to a specific site,
and drug bioavailability.
A schematic comparison of untargeted and targeted
drug delivery systems.
05 March. 2011 15M S Ramaiah Institute of Technology, Bangalore

16. 05 March. 2011 16M S Ramaiah Institute of Technology, Bangalore
Nanotechnology – based drug delivery
Systems

17. Nanotechnology – based drug delivery
Systems
Several anti-cancer drugs including paclitaxel,
doxorubicin, 5-fluorouracil and dexamethasone have
been successfully formulated using nanomaterials.
Polylactic/glycolic acid (PLGA) and polylactic acid
(PLA) based nanoparticles have been formulated to
encapsulate dexamethasone, a glucocorticoid with an
intracellular site of action.
05 March. 2011 17M S Ramaiah Institute of Technology, Bangalore

18. Nanotechnology – based drug delivery
Systems
Dexamethasone is a chemotherapeutic agent that has
anti-proliferative and anti-inflammatory effects.
The drug binds to the cytoplasmic receptors and the
subsequent drug-receptor complex is transported to
the nucleus resulting in the expression of certain
genesthat control cell proliferation.
05 March. 2011 18M S Ramaiah Institute of Technology, Bangalore

19. Nanotechnology – based drug delivery
Systems
These drug-loaded nanoparticles formulations that
release higher doses of drug for prolonged period of
time completely inhibited proliferation of vascular
smooth musclecells.
Colloidal drug delivery modalities such as liposomes,
micelles or nanoparticles have been intensively
investigated for their usein cancer therapy.
05 March. 2011 19M S Ramaiah Institute of Technology, Bangalore

20. Nanotechnology – based drug delivery
Systems
The effectiveness of drug delivery systems can be
attributed to their small size, reduced drug toxicity,
controlled timereleaseof thedrug and modification of
drug pharmacokineticsand biological distribution.
Too often, chemotherapy fails to cure cancer because
some tumor cells develop resistance to multiple
anticancer drugs.
05 March. 2011 20M S Ramaiah Institute of Technology, Bangalore

21. Nanotechnology – based drug delivery
Systems
In most cases, resistance develops when cancer cells
begin expressing a protein, known as p-glycoprotein
that is capable of pumping anticancer drugs out of a
cell as quickly as they cross through the cell's outer
membrane.
New research showsthat nanoparticlesmay beableto
get anticancer drugs into cells without triggering the
p-glycoprotein pump.
05 March. 2011 21M S Ramaiah Institute of Technology, Bangalore

22. Nanotechnology – based drug delivery
Systems
The researchers studied in vivo efficacy o f paclitaxel
lo aded nanoparticles in paclitaxel-resistant human
colorectal tumors.
Paclitaxel entrapped in emulsifying wax nanoparticles
was shown to overcome drug resistance in a human
colon adenocarcinomacell line(HCT-15).
05 March. 2011 22M S Ramaiah Institute of Technology, Bangalore

23. Nanotechnology – based drug delivery
Systems
Theinsolubility problemsencountered with paclitaxel
can be overcome by conjugating this drug with
albumin.
Paclitaxel bound to bio-compatible proteins like
albumin (Abraxane) is an injectable nano-suspension
approved for thetreatment of breast cancer.
05 March. 2011 23M S Ramaiah Institute of Technology, Bangalore

24. Nanotechnology – based drug delivery
Systems
The solvent Cremophor-EL used in previous
formulations of paclitaxel causes acute
hypersensitivity reactions.
To reduce the risk of allergic reactions when
receiving paclitaxel, patients must undergo pre-
medication using steroids and anti-histamines and be
given the drug using slow infusions lasting a few
hours.
05 March. 2011 24M S Ramaiah Institute of Technology, Bangalore

25. Nanotechnology – based drug delivery
Systems
Binding paclitaxel to albumin resulted in delivery of
higher doseof drug in short period of time.
Because it is solvent-free, solvent- related toxicities
arealso eliminated.
In Phase III clinical trial, the response rate of
Abraxane was about twice than that of the solvent-
containing drug Taxol.
05 March. 2011 25M S Ramaiah Institute of Technology, Bangalore

26. Drug Delivery Carriers
05 March. 2011 M S Ramaiah Institute of Technology, Bangalore 26

27. Recent Developments in NDDS
Several terminologies have been used to describe
nanoparticulatedrug delivery systems.
In most cases, either polymers or lipids are used as
carriers for the drug, and the delivery systems have
particle size distribution from few nanometers to few
hundred nanometers.
05 March. 2011 27M S Ramaiah Institute of Technology, Bangalore

28. 05 March. 2011 28M S Ramaiah Institute of Technology, Bangalore

29. Applications of Nanotechnology
05 March. 2011 29M S Ramaiah Institute of Technology, Bangalore

30. Applications of Nanotechnology
05 March. 2011 30M S Ramaiah Institute of Technology, Bangalore

31. Biomedical Applicationsof
Nanotechnology
05 March. 2011 31M S Ramaiah Institute of Technology, Bangalore

32. Biomedical nanotechnology
Three applications of nanotechnology are
particularly suited to biomedicine: diagnostic
techniques, drugs, and prostheses and implants.
Interest is booming in biomedical applications for
use outside the body, such as diagnostic sensors
and “labon- a-chip” techniques, which are suitable
for analyzing blood and other samples, and for
inclusion in analytical instruments for R&D on
new drugs.
05 March. 2011 32M S Ramaiah Institute of Technology, Bangalore

33. Biomedical nanotechnology
For inside the body, many companies are
developing nanotechnology applications for
anticancer drugs, implanted insulin pumps, and
gene therapy.
Other researchers are working on prostheses and
implants that include nanostructured materials.
05 March. 2011 33M S Ramaiah Institute of Technology, Bangalore

34. Diagnostics
Sensors for medical and environmental
monitoring and for preparing pure chemicals and
pharmaceuticals.
Light and strong materials for defence, aerospace,
automotive, and medical applications.
Lab-on-a-chip diagnostic techniques.
05 March. 2011 34M S Ramaiah Institute of Technology, Bangalore

35. Diagnostics
Sunscreens with ultraviolet-light absorbing
nanoparticles.
The following applications are expected in the next
decade:
• Longer-lasting medical implants.
• The capability to map an individual’s entire genetic code
almost instantaneously.
• The ability to extend life by 50% from present
expectations.05 March. 2011 35M S Ramaiah Institute of Technology, Bangalore

36. Nanodrugs
Pharmaceutical companies do not expect
nanostructured materials to become new drug
compounds.
However, carbon buckyballs and nanotubes might be
useful as drug delivery vehicles because their
nanometer size enables them to move easily inside the
body.
05 March. 2011 36M S Ramaiah Institute of Technology, Bangalore

37. Nanodrugs
The active compound might be inserted in a nanotube
or bonded to aparticle’ssurface.
Other types of nanopowders or biomolecules are also
useful and arecloser to themarketplace.
05 March. 2011 37M S Ramaiah Institute of Technology, Bangalore

38. Nanodrugs
In April 2002, American Pharmaceutical Partners
(Los Angeles) presented results from an early human
trial of ABI-007, a new nanoparticle delivery system
for an established anticancer drug.
ABI- 007 is 130 nm long and consists of an
engineered protein-stabilized nanoparticle that
contains paclitaxel, which is used to treat breast,
bladder, and morethan adozen other cancers.
05 March. 2011 38M S Ramaiah Institute of Technology, Bangalore

39. Nanodrugs
Such new delivery systems combine a drug with an
artificial vector that can enter the body and move in it
likeavirus.
 If more advanced clinical tests are successful, ABI-
007 islikely to enter themarket in afew years.
05 March. 2011 39M S Ramaiah Institute of Technology, Bangalore

40. Nanodrugs
Cosmetics based on quantum dots are already sold in
largequantities.
Nanophase Technologies Corp. (Romeoville, IL)
produces nanocrystalline materials such as zinc oxide
for usein sunscreensand other products.
The particles are protective and cause minimal
damageto DNA in sunlight.
05 March. 2011 40M S Ramaiah Institute of Technology, Bangalore

41. Nanodrugs
Quantum dots are manufactured between 3 and 5 nm,
suitablefor binding specific biomolecules.
The quantum dots are luminescent particles, more
stablethan theorganic diesused today.
They arenontoxic.
05 March. 2011 41M S Ramaiah Institute of Technology, Bangalore

42. Prostheses and implants
Nanotechnology also has applications in tissue
engineering.
New biomedical materials for bones, teeth, or other
tissues implant are developed using tailor-made
materials.
Biomimetic nanostructures start with a predefined
nanochemical or physical structure.
05 March. 2011 42M S Ramaiah Institute of Technology, Bangalore

43. Prostheses and implants
A nanochemical structure may be an array of large
reactive molecules attached to a surface, while a
nanophysical structuremay beasmall crystal.
Researchers hope that by using these nanostructures
as seed molecules or crystals, a material will keep
growing by itself.
05 March. 2011 43M S Ramaiah Institute of Technology, Bangalore

44. Prostheses and implants
Other groups want to apply nanostructured materials
in artificial sensory organs such as an electronic eye,
ear, or nerve.
Both featsarefar off.
05 March. 2011 44M S Ramaiah Institute of Technology, Bangalore

45. Equipments for Nanoparticles
1. Homogenizer
2. Ultra Sonicator
3. Mills
4. Spray Milling
5. Supercritical Fluid Technology
6. Electrospray
7. Ultracentrifugation
8. Nanofiltration
05 March. 2011 M S Ramaiah Institute of Technology, Bangalore 45

46. Homogenizer & Ultra Sonicator
05 March. 2011 M S Ramaiah Institute of Technology, Bangalore 46

47. ANY QUERIES?
05 March. 2011 47M S Ramaiah Institute of Technology, Bangalore

48. 4805 March. 2011 M S Ramaiah Institute of Technology, Bangalore
Cell No: 00919742431000
E-mail: bknanjwade@yahoo.co.in